[A new antitumor compound: hydroxy-9 ellipticin. Effect on mouse L 1210 leukemia].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice
D000970:Antineoplastic Agents; D002227:Carbazoles
Un nouveau composé anti-tumoral: l'hydroxy-9 ellipticine. Action sur la leucémie L 1210 de la souris